CE vs CVS · rev $10.28B vs P/E 16, rev $402.07B
Celanese Corporation (CE) versus CVS Health Corp (CVS) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
CE currently screens at market cap $5.92B. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Not investment advice. Open the CE and CVS stock pages for the full models.
Not investment advice.